Jim Cramer sees two paths ahead for Coterra Energy

Jim Cramer sees two paths ahead for Coterra Energy

Another Wall Street analyst has thrown their support behind Coterra Energy , adding to Jim Cramer’s belief that the oil and gas producer is a stock to watch in the new year. Bank of America on Friday upgraded Coterra to buy from a hold-equivalent rating, becoming the fourth research firm in less than a month … Read more

Meta was our second-best performer last year. What is in store for 2024?

Meta was our second-best performer last year. What is in store for 2024?

Meta Platforms ‘ savvy use of artificial intelligence and untapped potential in business messaging are reasons why we see more upside ahead for the stock in 2024. Meta reached a 52-week high of $361.90 per share on the second to last trading day of 2023. The stock nearly tripled last year and was the second-best … Read more

What to expect from Modelo and Corona beer maker Constellation Brands earnings

What to expect from Modelo and Corona beer maker Constellation Brands earnings

Everybody likes a comeback story. Constellation Brands ‘ stock has stalled, leaving long-time shareholders like us frustrated. However, the Mexican beer powerhouse has an opportunity to redeem itself with Friday’s quarterly earnings print. Constellation is set to report its fiscal 2024 third quarter before the opening bell. Analysts expect revenue to grow 2.5% to $2.5 … Read more

Eli Lilly shares rise on new DTC service for drugs. Cramer says hold on

Eli Lilly shares rise on new DTC service for drugs. Cramer says hold on

Eli Lilly is on track for a new high Thursday after unveiling a service aimed at making it easier for patients to access weight-loss drugs. Jim Cramer says investors should let LLY stock ride. The Club holding launched LillyDirect, a website that connects patients directly to a telehealth provider who can prescribe the drugmaker’s weight-loss … Read more

Cramer sees big PC refresh cycle coming. MSFT, AAPL, NVDA can benefit

Cramer sees big PC refresh cycle coming. MSFT, AAPL, NVDA can benefit

The rebound emerging in the personal computer market is getting a major boost thanks to artificial intelligence and Microsoft ‘s biggest keyboard change in decades. Microsoft announced Thursday that upcoming Windows PCs will soon have a designated key for its AI virtual assistant Copilot . This is one of the most prominent updates to the … Read more

These are the 11 stocks in our portfolio that Wall Street likes best

These are the 11 stocks in our portfolio that Wall Street likes best

The list of most-loved Club stocks on Wall Street entering the new year resembles the list of 2023 winners, except for two stocks: Constellation Brands and Disney . The Mexican beer importer and media-and-entertainment giant are among the 11 Club holdings with buy-equivalent ratings from at least 75% of the analysts who cover them, according … Read more

Palo Alto Networks hitting $100 billion in market cap is the beginning

Palo Alto Networks hitting 0 billion in market cap is the beginning

Palo Alto Networks this month became the first cybersecurity company to eclipse $100 billion in market value. We believe it can get plenty bigger. On Dec. 14, it traded above market cap milestone for the first time when shares hit an all-time intraday high of $318 each. The stock has yet to close above that … Read more

Only 2 are in the Magnificent Seven

Only 2 are in the Magnificent Seven

It was a big rebound year for stocks. The S & P 500 gained 24%, while the Dow rose 14% and the tech-heavy Nasdaq rose more than 43%. All three major averages were coming off big losses in 2022. Our portfolio of 33 stocks also bounced back. Throughout the year, we held onto our conviction … Read more

Nvidia has tripled this year. Cramer says the stock is still too cheap

Nvidia has tripled this year. Cramer says the stock is still too cheap

Nvidia — the star of the S & P 500 in 2023 — enters 2024 even cheaper than it was a year ago. Shares of the chipmaker, which more than tripled this year, are now valued at roughly 25 times forward earnings, down from 34 at the end of 2022, according to FactSet data. The … Read more

Obesity and Alzheimer’s drugs pack one-two punch to lift Eli Lilly

Obesity and Alzheimer’s drugs pack one-two punch to lift Eli Lilly

Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer … Read more